1. Home
  2. CUBI vs EVO Comparison

CUBI vs EVO Comparison

Compare CUBI & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Customers Bancorp Inc

CUBI

Customers Bancorp Inc

HOLD

Current Price

$66.21

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.47

Market Cap

821.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUBI
EVO
Founded
1994
1993
Country
United States
Germany
Employees
790
4766
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
821.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CUBI
EVO
Price
$66.21
$2.47
Analyst Decision
Buy
Strong Buy
Analyst Count
8
1
Target Price
$86.63
$7.00
AVG Volume (30 Days)
361.2K
110.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$25.24
N/A
Revenue Next Year
$9.30
$7.13
P/E Ratio
$11.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$40.75
$2.31
52 Week High
$82.56
$4.80

Technical Indicators

Market Signals
Indicator
CUBI
EVO
Relative Strength Index (RSI) 38.75 29.68
Support Level $64.71 N/A
Resistance Level $68.28 $3.78
Average True Range (ATR) 2.51 0.10
MACD -0.11 -0.08
Stochastic Oscillator 26.76 13.06

Price Performance

Historical Comparison
CUBI
EVO

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: